HOME >> BIOLOGY >> NEWS
Leading experts in field of gene therapy to meet in Minneapolis

The leading experts in the field of gene therapy will gather in Minneapolis, June 2-6, 2004, for the 7th Annual Meeting of the American Society of Gene Therapy (ASGT). New developments on the use of gene therapy for treating infections diseases such as cancer and AIDS, cardiovascular diseases, and cystic fibrosis will be showcased in a variety of educational workshops and symposia.

Program topics will also feature:

  • Innovative approaches of gene therapy
  • Long term follow up of gene therapy clinical trials
  • International harmonization of regulatory standards for clinical trials

Gordon Keller, MD, Mount Sinai School of Medicine, and Catherine Verfaillie, MD, University of Minnesota Health Center, will present the Presidential Symposium lecture. In addition, the premier George Stamatoyannopoulos lecture will be given by Harriet Robinson, MD, from the Yerkes Regional Primate Research Center.

Members of the media may register without charge for the ASGT 7th Annual Meeting. Press conferences on the latest research will be conducted throughout the meeting. A press room with interview space, computers, modem lines, telephone and facsimile services will also be available onsite for media representatives. To receive an annual meeting preliminary program, press conference schedule, or registration materials, contact John Gardner at 414-278-1341 or jgardner@execinc.com.

The ASGT is the largest medical professional organizations representing researchers and scientists dedicated to discovering new gene therapies. Established in 1996, the ASGT has grown to nearly 3,000 members. ASGT is committed to promoting and fostering the exchange and dissemination of information and ideas related to gene therapy and encouraging the general field of research.

For more information, contact John Gardner at 414/278-1341 or visit www.asgt.org


'"/>

Contact: John Gardner
jgardner@execinc.com
414-278-1341
American Academy of Allergy, Asthma & Immunology
5-Apr-2004


Page: 1

Related biology news :

1. Leading scientists design new framework for biodiversity conservation
2. Leading science, higher-education and engineering groups urge six improvements to U.S. visa quagmire
3. Leading U.S. gun manufacturer joins NJIT to develop personalized handgun
4. Leading bacterial pathogen is sequenced
5. Leading cloning experts challenge Clonaid to prove claim
6. Leading cancer research organization urges FDA to speed approval of drugs for precancers
7. Leading lab expert to update medical community on diagnostic testing for thyroid function
8. Leading indoor environment experts to convene at Syracuse University to discuss air quality and urban environments
9. Leading snake expert dies at 38
10. Leading experts address safety and economics of biotech crops
11. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leading experts field gene therapy meet Minneapolis

(Date:3/2/2015)... VILNIUS, Lithuania , March 2, 2015   ... AI technologies, today introduced the SentiGaze Software Development ... developers to create applications that use off-the-shelf webcams to ... a user gazes at a monitor. Heatmaps can be ... determining the effectiveness of online advertising. The SDK can ...
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
(Date:3/4/2015)... 04, 2015 USDM Life Sciences ... life sciences industry, hired David Blewitt as ... Cloud Compliance Services and Solutions at USDM Life Sciences ... applications while maintaining compliance with government regulations worldwide. ... an accomplished life sciences regulatory and IS compliance professional ...
(Date:3/4/2015)... 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) (the "Company") ... collaborative research program with Emerald Logic, a ... Evolution Technology (FACET), Emerald Logic analyzed Resverlogix,s ... from each of 798 patients who participated ... ASSERT, SUSTAIN and ASSURE. The objective of ...
(Date:3/4/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of innovative therapies ... today announced that it will release fourth quarter ... on Monday, March 9th, 2015. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on March ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Reaction (PCR) represents one of the fastest growing technologies ... cell biologists in subcellular visualization is driving growth in ... need for deeper understanding of gene expressions will continue ... market. Expanding applications in fields ranging from pharma, biotech, ...
Breaking Biology Technology:USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
Cached News: